Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Endocrinology and Metabolism (Seoul, Korea)|September 29, 2017
CTNNB1 Mutation in Aldosterone Producing AdenomaJian Jhong Wang, Kang Yung Peng, Vin Cent Wu, et al.
The Journal of Physical Chemistry. B|July 21, 2006
Well-packed chains and aggregates in the emission mechanism of conjugated polymersKang-Yung Peng, Show-An Chen, Wun-Shain Fann, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|July 16, 2011
Antiosteoporotic Activity of Dioscorea alata L. cv. Phyto through Driving Mesenchymal Stem Cells Differentiation for Bone FormationKang-Yung Peng, Lin-Yea Horng, Hui-Ching Sung, et al.
Metabolism: Clinical and Experimental|November 3, 2010
Hepatocyte growth factor has a role in the amelioration of diabetic vascular complications via autophagic clearance of advanced glycation end products: Dispo85E, an HGF inducer, as a potential botanical drugKang-Yung Peng, Lin-Yea Horng, Hui-Ching Sung, et al.
Kidney Research and Clinical Practice|June 16, 2026
Real-world trends in glucagon-like peptide-1 receptor agonists prescribing in acute kidney disease: a global federated-network study of dialysis-requiring acute kidney injury survivorsHeng-Chih Pan, Chung-An Wang, Jui-Yi Chen, et al.
Endocrinology and Metabolism (Seoul, Korea)|December 2, 2020
Changes in Glucose Metabolism after Adrenalectomy or Treatment with a Mineralocorticoid Receptor Antagonist for Primary AldosteronismYu-Fang Lin, Kang-Yung Peng, Chia-Hui Chang, et al.
British Journal of Pharmacology|March 28, 2013
Activation of mitochondrial function and Hb expression in non-haematopoietic cells by an EPO inducer ameliorates ischaemic diseases in micePei-Lun Hsu, Lin-Yea Horng, Kang-Yung Peng, et al.
Biomedicines|September 28, 2021
Novel Mutations Detection with Next-Generation Sequencing and Its Association with Clinical Outcome in Unilateral Primary AldosteronismChe-Hsiung Wu, Kang-Yung Peng, Daw-Yang Hwang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|December 14, 2023
The predictors of long-term outcomes after targeted therapy for primary AldosteronismYing-Ying Chen, Shun-Chen Huang, Chien-Ting Pan, et al.
Frontiers in Endocrinology|May 17, 2021
NP-59 Adrenal Scintigraphy as an Imaging Biomarker to Predict <i>KCNJ5</i> Mutation in Primary Aldosteronism PatientsChing-Chu Lu, Ruoh-Fang Yen, Kang-Yung Peng, et al.
Pageof 5